FDA Inspection
ImpactLifeImpactLife – FDA Inspection, Apr 22, 2013
Record Details
This FDA Inspection record concerns ImpactLife, with an inspection on April 22, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- ImpactLife
- Inspection Date
- April 22, 2013
- Product Type
- Biologics
View Company Profile
ID · c9816c9f-d243-4e3c-a7ab-4fbd04f3cc6f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 828388
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.40Clean & orderly
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ImpactLife
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 26, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 11, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 17, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 21, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for ImpactLife
- FDA Inspection 1178326 - 2022-08-26
- FDA Inspection 1022638 - 2017-07-11
- FDA Inspection 919931 - 2015-03-17
- FDA Inspection 694631 - 2010-10-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.